State of Alaska Department of Revenue Has $751,000 Stake in Progyny, Inc. (NASDAQ:PGNY)

State of Alaska Department of Revenue grew its stake in Progyny, Inc. (NASDAQ:PGNY) by 397.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 44,819 shares of the company’s stock after purchasing an additional 35,813 shares during the period. State of Alaska Department of Revenue’s holdings in Progyny were worth $751,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Quarry LP boosted its position in Progyny by 1,900.0% in the second quarter. Quarry LP now owns 880 shares of the company’s stock valued at $25,000 after buying an additional 836 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Progyny during the 2nd quarter valued at $44,000. Mendota Financial Group LLC acquired a new stake in shares of Progyny during the 3rd quarter valued at $56,000. Cambridge Trust Co. bought a new stake in Progyny during the 1st quarter worth $95,000. Finally, 1620 Investment Advisors Inc. acquired a new position in Progyny in the 2nd quarter worth about $97,000. 94.93% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on PGNY shares. Cantor Fitzgerald reissued an “overweight” rating and set a $25.00 price target on shares of Progyny in a research note on Tuesday, October 1st. JMP Securities lowered shares of Progyny from an “outperform” rating to a “market perform” rating in a report on Thursday, September 19th. JPMorgan Chase & Co. decreased their price target on shares of Progyny from $31.00 to $22.00 and set an “overweight” rating for the company in a research report on Thursday, September 19th. Jefferies Financial Group cut their price target on shares of Progyny from $31.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday, September 19th. Finally, Leerink Partnrs cut shares of Progyny from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 7th. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, Progyny currently has an average rating of “Hold” and an average price target of $27.73.

Progyny Trading Up 3.7 %

Shares of PGNY opened at $16.38 on Thursday. The firm’s fifty day simple moving average is $18.50 and its two-hundred day simple moving average is $24.18. Progyny, Inc. has a 12 month low of $13.93 and a 12 month high of $42.08. The stock has a market capitalization of $1.48 billion, a P/E ratio of 25.48, a price-to-earnings-growth ratio of 1.43 and a beta of 1.44.

Progyny (NASDAQ:PGNY) last released its earnings results on Tuesday, August 6th. The company reported $0.17 EPS for the quarter, hitting the consensus estimate of $0.17. The business had revenue of $304.09 million during the quarter, compared to analysts’ expectations of $305.32 million. Progyny had a return on equity of 11.97% and a net margin of 5.54%. The firm’s revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.15 earnings per share. As a group, research analysts predict that Progyny, Inc. will post 0.64 EPS for the current fiscal year.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.